BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $1.387B (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 49.5%

Value $687M Shares 8,592,007 Est. Cost $8.21 Unrealized +807.0%

MNST MONSTER BEVERAGE CORP NEW 26.8%

Value $372M Shares 4,656,488 Est. Cost $22.71 Unrealized +84.7%

IWM ISHARES TR 10.2%

Value $142M Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 7.5%

Value $105M Shares 760,062 Est. Cost $27.50 Unrealized +398.8%

LCTX LINEAGE CELL THERAPEUTICS IN 3.9%

Value $53.8M Shares 34,935,485 Est. Cost $1.04 Unrealized +48.5%

— ONCOCYTE CORP 1.9%

Value $25.85M Shares 17,349,945 Est. Cost $3.38 Unrealized —

— AGEX THERAPEUTICS INC 0.2%

Value $2.56M Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	8,592,007	$687M	49.5%	$8.21	+807.0%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$372M	26.8%	$22.71	+84.7%	COM	61174X109
IWM	ISHARES TR	690,000	$142M	10.2%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$105M	7.5%	$27.50	+398.8%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,935,485	$53.8M	3.9%	$1.04	+48.5%	COM	53566P109
—	ONCOCYTE CORP	17,349,945	$25.85M	1.9%	$3.38	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$2.56M	0.2%	$2.99	—	COM	00848H108